Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000062

EVP, Chief Financal Officer sold 7,000 shares at an average $73.83 ($516,830)

  • EVP, Chief Financal Officer acquired 58,704 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sylvain Jereme M · EVP, Chief Financal Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-08 Grant or award : show line 1 in the form 10b5-1 +35,906 119,684 D
2025-03-08 Grant or award : show line 2 in the form 10b5-1 +22,798 142,482 D
2025-03-10 Sale : show line 3 in the form 10b5-1 −2,670 $73.22 $195,489 139,812 D
2025-03-10 Sale : show line 4 in the form 10b5-1 −3,203 $74.04 $237,151 136,609 D
2025-03-10 Sale : show line 5 in the form 10b5-1 −1,127 $74.70 $84,189 135,482 D
Open-market sales · 7,000 sh · avg $73.83 · $516,830
Loading xslF345X05/wk-form4_1741735014.xml…